Announcements Trials
Browse Landscape

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 9Observational 3

Sponsor

Cancer Type

Genitourinary 2Head & Neck 1Endocrine 1

Conditions

Prostatic Neoplasms 2Thyroid Cancer, Papillary 1Adenocarcinoma 1

Interventions

Blood Specimen Collection 135Surveys and Questionnaires 132Specimen Handling 57Observation 55Radiotherapy 43Interviews as Topic 35Surgical Procedures, Operative 31Biopsy 30Drug Therapy 30Data Collection 25Magnetic Resonance Spectroscopy 25Nivolumab 21Immune Checkpoint Inhibitors 18Watchful Waiting 18Standard of Care 17Therapeutics 17Immunotherapy 16Magnetic Resonance Imaging 16trastuzumab deruxtecan 14Liquid Biopsy 13Restraint, Physical 13Tomography, X-Ray Computed 13palbociclib 13Radiosurgery 12enzalutamide 12Focus Groups 11Hematologic Tests 11apalutamide 11darolutamide 11pembrolizumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Transurethral Resection of Prostate × 1 year × Clear all
NCT07237399 2026-05-13

TA-P-OLIM

University Hospital, Ghent

Withdrawn
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06316895 2026-03-20

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

Chinese PLA General Hospital

Recruiting
3,772 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT06705803 2026-02-02

Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)

University of Chicago

Recruiting
3,000 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡